1.     Ross MH, Romrell LJ and Kaye GI (1995) Histology A Text and Atlas, Third Edition, Williams and Wilkins International Edition.

2.     Williams PL, Bannister LH, Berry MM, Collins P, Dyson M, Dussek JE et al(1995):  Gray’s Anatomy Ed. by LH Bannister and M Dyson, Thirty-Eighth Edition, Churcill Livingstone Inc. New York.

3.     McGee J.O.D., Isaacson P.G. and Wright N.A.(1992): Oxford Textbook of Pathology. Oxford University Press.Volume:1.

4.     Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T.(1998):Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res, 58(23):5466-72 Dec 1.

5.     Bisgrove DA; Godbout R.(1999):Differential expression of AP-2alpha and AP-2beta in the developing chick retina: repression of R-FABP promoter activity by AP-2.  Dev Dyn, 214(3):195-206  Mar.

6.     Luca MR; Bar-Eli M.(1998):Molecular changes in human melanoma metastasis. Histol Histopathol, 13(4):1225-31  Oct.

7.     Ohta T; Michel JJ; Schottelius AJ; Xiong Y.(1999):ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol Cell, 3(4):535-41  Apr.

8.     Ohta T; Michel JJ; Xiong Y.(1999):Association with cullin partners protects ROC proteins from proteasome-dependent degradation. Oncogene, 18(48):6758-66  Nov 18.

9.     Barlow C; Liyanage M; Moens PB; Tarsounas M; Nagashima K; Brown K; Rottinghaus S; Jackson SP; Tagle D; Ried T; Wynshaw-Boris A (1998):Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I. Development, 125(20):4007-17  Oct.

10.  de Toledo SM; Azzam EI; Keng P; Laffrenier S; Little JB.(1998):Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1. Cell Growth Differ, 9(11):887-96  Nov.

11.  Lee WY; Jin YT; Chang TW; Lin PW; Su IJ.(1999):Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters. Histopathology, 34(2):106-12  Feb.

12.  Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; Espana P; Bonilla F. (1999): Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer. Breast Cancer Res Treat, 53(1):9-17 Jan.

13.  Bhuiyan ZA; Yatsuki H; Sasaguri T; Joh K; Soejima H; Zhu X; Hatada I; Morisaki H; Morisaki T; Mukai T.(1999):Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome. Hum Genet, 104(3):205-10  Mar. 

14.  Kube D; Vockerodt M; Weber O; Hell K; Wolf J; Haier B; Grasser FA; Muller-Lantzsch N; Kieff E; Diehl V; Tesch H. (1999): Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428. J Virol, 73(2):1630-6  Feb.

15.  Van Leeuwen-Stok EA; Jonkhoff AR; Visser-Platier AW; Drager LM; Teule GJ; Huijgens PC; Schuurhuis GJ.(1998):Cell cycle dependency of 67gallium uptake and cytotoxicity in human cell lines of hematological malignancies.  Leuk Lymphoma, 31(5-6):533-44  Nov.

16.  Singer JD; Gurian-West M; Clurman B; Roberts JM.(1999):Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev, 13(18):2375-87  Sep 15.

17.  Shiyanov P; Nag A; Raychaudhuri P. (1999): Cullin 4A associates with the UV-damaged DNA-binding protein DDB.  J Biol Chem, 274(50):35309-12  Dec 10.

18.  Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K (1999):Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. J Mol Cell Cardiol, 31(10):1857-62  Oct.

19.  Ozawa E; Hagiwara Y; Yoshida M. (1999):Creatine kinase, cell membrane and Duchenne muscular dystrophy. Mol Cell Biochem, 190(1-2):143-51  Jan.

20.  Rosai J(1996): Ackerman’s Surgical Pathology. Eighth Edition. Mosby Publishing.    Volume: 1.

21.  Inadomi T; Tan M; Suzuki H; Shigematsu C.(1999):Immunohistochemical evaluation of the probability of skin metastasis in gastric cancer. Eur J Dermatol, 9(3):214-7  Apr-May.

22.  Niewiadomska H; Mirowski M; Stempien M; Olborski B; Blonski JZ; Hanausek M; Wierzbicki R.(1998):A 65 kDa oncofetal protein (p65), proliferating cell nuclear antigen (PCNA) and Ki67 expression in breast cancer patients. Neoplasma, 45(4):216-22.

23.  Lalwani AK; Attaie A; Randolph FT; Deshmukh D; Wang C; Mhatre A; Wilcox E (1998):Point mutation in the MITF gene causing Waardenburg syndrome type II in a three-generation Indian family.  Am J Med Genet, 80(4):406-9  Dec 4.

24.  Price ER; Horstmann MA; Wells AG; Weilbaecher KN; Takemoto CM; Landis MW; Fisher DE.(1998):alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem, 273(49):33042-7  Dec 4.

25.  Yajima I; Sato S; Kimura T; Yasumoto K; Shibahara S; Goding CR; Yamamoto H (1999):An L1 element intronic insertion in the black-eyed white (Mitf[mi-bw]) gene: the loss of a single Mitf isoform responsible for the pigmentary defect and inner ear deafness. Hum Mol Genet, 8(8):1431-41  Aug.

26.  Martelli AM; Bortul R; Fackelmayer FO; Tazzari PL; Bareggi R; Narducci P; Zweyer M (1999):Biochemical and morphological characterization of the nuclear matrix from apoptotic HL-60 cells. J Cell Biochem, 72(1):35-46  Jan 1.

27.  Briggman J; Genduso R; Camara C; Healy B; Shapiro K; Roos R; Merrifield S; Lifter J; Wu YJ; Elder E; Talamonti M.(1999):NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancer. Anticancer Res, 19(4A):2411-4  Jul-Aug.

28.  Hasholzner U; Stieber P; Zimmermann A; Burges A; Hofmann K; Schmitt UM; Schmeller N; Schalhorn A.(1999): Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases. Anticancer Res, 19(4A):2415-20 Jul-Aug.

29.  Charrasse S; Carena I; Hagmann J; Woods-Cook K; Ferrari S (1999): Characterization, subcellular distribution, and cell cycle-dependent kinase activity. Cell Growth Differ, 10(9):611-20 Sep.

30.  Besset V; Rhee K; Wolgemuth DJ (1999):The cellular distribution and kinase activity of the Cdk family member Pctaire1 in the adult mouse brain and testis suggest functions in differentiation. Cell Growth Differ, 10(3):173-81  Mar.

31.  Echeverria OM; Hern´andez-Pando R; Vazquez-Nin GH(1998):Ultrastructural, cytochemical, and immunocytochemical study of nuclei and cytoskeleton of thyroid papillary carcinoma cells.  Ultrastruct Pathol, 22(3):185-97  May-Jun.

32.  Kaskel P; Berking C; Sander S; Volkenandt M; Peter RU; Krahn G.(1999): S-100 protein in peripheral blood: a marker for melanoma metastases: a prospective 2-center study of 570 patients with melanoma. J Am Acad Dermatol, 41(6):962-9  Dec.

33.  Keller T; Bitterlich N; Hilfenhaus S; Bigl H; Loser T; Leonhardt P(1998): Tumour markers in the diagnosis of bronchial carcinoma: new options using fuzzy logic-based tumour marker profiles. J Cancer Res Clin Oncol, 124(10):565-74.

34.  Baldi A; Esposito V; De Luca A; Howard CM; Mazzarella G; Baldi F; Caputi M; Giordano A.(1996):Differential expression of the retinoblastoma gene family members pRb/p105, p107, and pRb2/p130 in lung cancer. Clin Cancer Res, 2(7):1239-45  Jul.

35.  Doostzadeh-Cizeron J; Evans R; Yin S; Goodrich DW.(1999):Apoptosis induced by the nuclear death domain protein p84N5 is inhibited by association with Rb protein. Mol Biol Cell, 10(10):3251-61  Oct.

36.  Knudsen KE; Weber E; Arden KC; Cavenee WK; Feramisco JR; Knudsen ES (1999): The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death. Oncogene, 18(37):5239-45 Sep 16.

37.  Korchynskyi O; Landstrom M; Stoika R; Funa K; Heldin CH; ten Dijke P; Souchelnytskyi S.(1999): Expression of Smad proteins in human colorectal cancer. Int J Cancer, 82(2):197-202  Jul 19.

38.  Pouliot F; Labrie C.(1999):Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens.Int J Cancer, 81(1):98-103  Mar 31.

39.  Fujii M; Takeda K; Imamura T; Aoki H; Sampath TK; Enomoto S; Kawabata M; Kato M; Ichijo H; Miyazono K.(1999): Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell, 10(11):3801-13  Nov.

40.  Hofbauer LC; Gori F; Riggs BL; Lacey DL; Dunstan CR; Spelsberg TC; Khosla S (1999): Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology, 140(10):4382-9  Oct.

41.  Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL.(1999): Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J Cell Biochem, 72(2):251-61 Feb 1.

42.  Yasuda H; Shima N; Nakagawa N; Yamaguchi K; Kinosaki M; Goto M; Mochizuki SI; Tsuda E; Morinaga T; Udagawa N; Takahashi N; Suda T; Higashio K.(1999):A novel molecular mechanism modulating osteoclast differentiation and function. Bone, 25(1):109-13  Jul.

43.  Rajcani J; Vojvodova A.(1998):The role of herpes simplex virus glycoproteins in the virus replication cycle. Acta Virol, 42(2):103-18  Apr.

44.  Yu KY; Kwon B; Ni J; Zhai Y; Ebner R; Kwon BS.(1999):A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem, 274(20):13733-6  May 14.

45.  Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G. (1999): Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.Clin Cancer Res, 5(8):2048-58  Aug.

46.  Nakamura Y; Saito K; Furusawa S.(1999):Analysis of internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma. Br J Haematol, 105(1):274-7  Apr.

47.  Basu A; Haldar S(1998):The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod, 4(12):1099-109  Dec.

48.  Kramer MH; Hermans J; Wijburg E; Philippo K; Geelen E; van Krieken JH; de Jong D; Maartense E; Schuuring E; Kluin PM.(1998): Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood, 92(9):3152-62 Nov 1.

49.  Ree HJ; Kadin ME; Kikuchi M; Ko YH; Suzumiya J; Go JH.(1999):Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. Hum Pathol, 30(4):403-11  Apr.

50.  Sirri V; Roussel P; Hernandez-Verdun D.(2000): The AgNOR proteins: qualitative and quantitative changes during the cell cycle. Micron, 31(2):121-6 Apr.

51.  Costa A de L; de Araujo NS; Pinto D dos S Jr; de Araujo VC.(1999):  PCNA/AgNOR and Ki-67/AgNOR double staining in oral squamous cell carcinoma. J Oral Pathol Med, 28(10):438-41Nov.

52.  Ceccarelli C; Trere D; Santini D; Taffurelli M; Chieco P; Derenzini M.(2000): AgNORs in breast tumours. Micron, 31(2):143-9  Apr.

53.  You Z; Komamura Y; Ishimi Y.(1999):Biochemical analysis of the intrinsic Mcm4-Mcm6-mcm7 DNA helicase activity. Mol Cell Biol, 19(12):8003-15  Dec.

54.  Fujita M; Yamada C; Goto H; Yokoyama N; Kuzushima K; Inagaki M; Tsurumi T.(1999): Cell cycle regulation of human CDC6 protein. Intracellular localization, interaction with the human mcm complex, and CDC2 kinase-mediated hyperphosphorylation. J Biol Chem, 274(36):25927-32  Sep 3.

55.  Williams GH; Romanowski P; Morris L; Madine M; Mills AD; Stoeber K; Marr J; Laskey RA; Coleman N.(1998): Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A, 95(25):14932-7  Dec 8.

56.  Pati D; Meistrich ML; Plon SE.(1999):Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis. Mol Cell Biol, 19(7):5001-13  Jul.

57.  Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjanen K; Kosma VM (1999): Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer, 80(12):2001-7  Aug.

58.  Huuhtanen RL; Blomqvist CP; Bohling TO; Wiklund TA; Tukiainen EJ; Virolainen M; Tribukait B; Andersson LC.(1999):Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res, 59(12):2885-90  Jun 15.

59.  Palazon LS; Davies TJ; Gardner RL.(1998):Translational inhibition of cyclin B1 and appearance of cyclin D1 very early in the differentiation of mouse trophoblast giant cells. Mol Hum Reprod, 4(11):1013-20  Nov.

60.  Caputi M; Groeger AM; Esposito V; Dean C; De Luca A; Pacilio C; Muller MR; Giordano GG; Baldi F; Wolner E; Giordano A.(1999):Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen. Am J Respir Cell Mol Biol, 20(4):746-50  Apr.

61.  Mishina T; Dosaka-Akita H; Kinoshita I; Hommura F; Morikawa T; Katoh H; Kawakami Y.(1999):Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome. Br J Cancer, 80(8):1289-95  Jun.

62.  Adamson A; Perkins S; Brambilla E; Tripp S; Holden J; Travis W; Guinee D Jr (1999): Proliferation, C-myc, and cyclin D1 expression in diffuse alveolar damage: potential roles in pathogenesis and implications for prognosis. Hum Pathol, 30(9):1050-7  Sep.

63.  Keum JS; Kong G; Yang SC; Shin DH; Park SS; Lee JH; Lee JD.(1999):Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer. Br J Cancer, 81(1):127-32  Sep.

64.  Liu Q; VanHoy RW; Zhou JH; Dantzer R; Freund GG; Kelley KW.(1999): Elevated cyclin E levels, inactive retinoblastoma protein, and suppression of the p27(KIP1) inhibitor characterize early development of promyeloid cells into macrophages. Mol Cell Biol, 19(9):6229-39  Sep.

65.  Dimri GP; Itahana K; Acosta M; Campisi J.(2000):Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol Cell Biol, 20(1):273-85  Jan.

66.  Spyridopoulos I; Principe N; Krasinski KL; Xu Sh; Kearney M; Magner M; Isner JM; Losordo DW.(1998): Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-alpha-induced apoptosis. Circulation, 98(25):2883-90  Dec 22-29.

67.  McCaffrey J; Yamasaki L; Dyson NJ; Harlow E; Griep AE.(1999):Disruption of retinoblastoma protein family function by human papillomavirus type 16 E7 oncoprotein inhibits lens development in part through E2F-1. Mol Cell Biol, 19(9):6458-68  Sep.

68.  Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S; Haase G; Ritchey M; Kelalis P; D'Angio GJ.(1998): Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol, 16(12):3744-51 Dec.

69.  Caspary T; Cleary MA; Perlman EJ; Zhang P; Elledge SJ; Tilghman SM.(1999): Oppositely imprinted genes p57(Kip2) and igf2 interact in a mouse model for Beckwith-Wiedemann syndrome. Genes Dev, 13(23):3115-24  Dec 1.

70.  Mori A; Higashi H; Hoshikawa Y; Imamura M; Asaka M; Hatakeyama M (1999):Granulocytic differentiation of myeloid progenitor cells by p130, the retinoblastoma tumor suppressor homologue. Oncogene, 18(46):6209-21  Nov 4.

71.  Fanarraga ML; P´arraga M; Aloria K; del Mazo J; Avila J; Zabala JC.(1999): Regulated expression of p14 (cofactor A) during spermatogenesis. Cell Motil Cytoskeleton, 43(3):243-54.

72.  Baur AS; Shaw P; Burri N; Delacretaz F; Bosman FT; Chaubert P.(1999):Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas.  Blood, 94(5):1773-81  Sep 1.

73.  Xaus J; Valledor AF; Cardo M; Marques L; Beleta J; Palacios JM; Celada A.(1999): Adenosine inhibits macrophage colony-stimulating factor-dependent proliferation of macrophages through the induction of p27kip-1 expression. J Immunol, 163(8):4140-9  Oct 15.

74.  Shoji M; Dobashi Y; Morinaga S; Jiang SX; Kameya T.(1999): Tumor extension and cell proliferation in adenocarcinomas of the lung. Am J Pathol, 154(3):909-18  Mar.

75.  Salh B; Bergman D; Marotta A.; Pelech SL.(1999): Differential cyclin-dependent kinase expression and activation in human colon cancer. Anticancer Res, 19(1B):741-8  Jan-Feb.

76.  Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH. (1999): Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.  Nature, 402(6762):615-22  Dec 9.

77.  Musa FR; Tokuda M; Kuwata Y; Ogawa T; Tomizawa K; Konishi R; Takenaka I; Hatase O.(1998): Expression of cyclin-dependent kinase 5 and associated cyclins in Leydig and Sertoli cells of the testis. J Androl, 19(6):657-66 Nov-Dec.

78.  Nakano S; Akiguchi I; Nakamura S; Satoi H; Kawashima S; Kimura J.(1999):Aberrant expression of cyclin-dependent kinase 5 in inclusion body myositis. Neurology, 53(8):1671-6  Nov 10.